Category: Company News

Frequency Holdings has begun using ReachOut Digital Intelligence’s new Capchase Pay facility, converting a multi-year customer agreement into upfront cash without issuing equity or adding debt at the parent-company level. Key Investor Takeaways Why FRQN Stock Is in Focus Frequency Holdings has activated the $5 million financing capacity secured by its wholly owned ReachOut Digital…

Rademikibart significantly reduced treatment failure and new moderate-to-severe COPD exacerbations in the Seabreeze STAT study, while Connect Biopharma said it plans to discuss a Phase 3 registrational program with the FDA. Key Investor Takeaways Why CNTB Stock Is in Focus Connect Biopharma reported preliminary topline results from its randomized, double-blind, placebo-controlled Phase 2 Seabreeze STAT…

Sono-Tek’s largest aggregate customer order to date covers 10 production-scale coating systems, adding to more than $10.79 million of backlog across two major programs expected primarily to ship during fiscal 2028. Key Investor Takeaways Why SOTK Stock Is in Focus Sono-Tek has secured approximately $7.19 million of orders from an existing clean energy customer, comprising…

Valion Bio and Shear Kershman Laboratories have completed formulation work for oral mucosal Entolimod, with the next study set to determine whether the needle-free approach can deliver measurable levels of the biologic into the bloodstream. Key Investor Takeaways Why VBIO Stock Is in Focus Valion Bio and Shear Kershman Laboratories have completed the formulation stage…

DarkIris is preparing its AI-powered film production platform for international launch while building a North American operating presence and extending its technology into interactive entertainment. Key Investor Takeaways Why DKI Stock Is in Focus DarkIris is moving closer to the international launch of Cine3.AI while establishing the commercial infrastructure intended to support its expansion into…

Silexion Therapeutics has moved SIL204 into active patient treatment, beginning a multinational Phase 2/3 study that will evaluate the RNAi candidate alongside standard chemotherapy in locally advanced pancreatic cancer. Key Investor Takeaways Why SLXN Stock Is in Focus Silexion has dosed the first patient worldwide in its Phase 2/3 clinical trial of SIL204, marking the…

The pool and spa retailer has entered a lender-backed restructuring that would cut about $685 million of funded debt, bring in new financing and shift majority ownership to existing lenders. Key Investor Takeaways Why LESL Stock Is in Focus Leslie’s has initiated a prearranged Chapter 11 restructuring designed to reduce its debt burden, secure additional…

Decent Holding’s SunCare business has launched an RMB 500-per-month AI-powered in-home senior care service through a strategic collaboration with Ruilan International, introducing a recurring subscription model to its existing base of approximately 200,000 estimated paid members. Key Investor Takeaways Why DXST Stock Is in Focus Decent Holding is extending its SunCare community-based senior care network…

BIO-key International has formed a strategic partnership with Dubai-based Al Majlis Group to expand its biometric identity and access management technology across government and private-sector organizations in the UAE and Saudi Arabia. Key Investor Takeaways Why BKYI Stock Is in Focus BIO-key is strengthening its Middle East expansion strategy through a partnership intended to provide…

SoundThinking has agreed to be acquired by Transom Capital Group for $8.00 per share in upfront cash plus a contingent value right worth up to another $3.00 per share, potentially valuing the transaction at approximately $159 million including the maximum CVR payment. Key Investor Takeaways Why SSTI Stock Is in Focus SoundThinking has entered into…